Compare RVSB & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVSB | ADVB |
|---|---|---|
| Founded | 1923 | 2014 |
| Country | United States | United States |
| Employees | N/A | 31 |
| Industry | Savings Institutions | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.9M | 109.2M |
| IPO Year | 1997 | N/A |
| Metric | RVSB | ADVB |
|---|---|---|
| Price | $5.10 | $4.27 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 38.3K | ★ 174.9K |
| Earning Date | 04-28-2026 | 02-13-2026 |
| Dividend Yield | ★ 1.58% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.67 | N/A |
| Revenue Next Year | $9.82 | N/A |
| P/E Ratio | $28.17 | ★ $1.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.74 | $0.19 |
| 52 Week High | $6.59 | $5.82 |
| Indicator | RVSB | ADVB |
|---|---|---|
| Relative Strength Index (RSI) | 36.24 | 57.88 |
| Support Level | $5.03 | $0.36 |
| Resistance Level | $5.19 | $5.75 |
| Average True Range (ATR) | 0.13 | 0.48 |
| MACD | -0.03 | -0.20 |
| Stochastic Oscillator | 18.00 | 13.02 |
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.